Immunotherapy in renal cell carcinoma

Lancet Oncol. 2023 Nov;24(11):1164-1166. doi: 10.1016/S1470-2045(23)00473-4. Epub 2023 Oct 13.

Authors

Vishal Navani¹, Daniel Y C Heng²

Affiliations

¹ Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada; University of Calgary, Calgary, AB, Canada. Electronic address: vishal.navani@ahs.ca.
² Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada; University of Calgary, Calgary, AB, Canada.

PMID: 37844599
DOI: 10.1016/S1470-2045(23)00473-4

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Renal Cell* / drug therapy
Carcinoma, Renal Cell* / pathology
Humans
Immunotherapy / adverse effects
Kidney Neoplasms* / pathology
Kidney Neoplasms* / therapy